domperidone < dopamine < dopamine D2 receptors

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]

Ident.	Authors (with country if any)	Title
000147 (2003)	Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Dagmar Galter [Suède] ; Erik Jönsson [Suède] ; Göran Sedvall [Suède] ; Lars Farde [Suède] ; J Gustavsson [Suède] ; Hans Bergman [Suède] ; Kodavali Chowdari [États-Unis] ; Vishwajit Nimgaonkar [États-Unis] ; Maria Anvret [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède]	NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits
000252 (2001)	S. Thobois [France] ; S. Guillouet [France] ; E. Broussolle [France]	Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease
000334 (2010)	David Devos [France] ; L Defebvre [France] ; R Bordet [France]	Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease
000389 (2009)	Ji Lee [Corée du Sud] ; Hae Shin [Corée du Sud] ; Kyung Kim [Corée du Sud] ; Young Sohn [Corée du Sud]	Factors contributing to the development of restless legs syndrome in patients with Parkinson disease
000405 (2006)	J Winkelman [États-Unis]	Considering the causes of RLS
000407 (2005)	Karen Smith [États-Unis] ; Lorri Bauer [États-Unis] ; Mariellen Fischer [États-Unis] ; Russell Barkley [États-Unis] ; Bradford Navia [États-Unis]	Identification and characterization of human NR4A2 polymorphisms in attention deficit hyperactivity disorder
000411 (2004)	Evelien Huisman [Pays-Bas] ; Harry Uylings [Pays-Bas] ; Piet Hoogland [Pays-Bas, Afrique du Sud]	A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease
000414 (2006)	J Winkelman [États-Unis]	Considering the causes of RLS
000508 (2011)	A Stoessl [Canada] ; David Brooks [Royaume-Uni] ; David Eidelberg [États-Unis]	Milestones in neuroimaging
000509 (2010)	Alessandro Dalpiaz [Italie] ; Barbara Cacciari [Italie] ; Matteo Mezzena [Italie] ; Mariangela Strada [Italie] ; Santo Scalia [Italie]	Solid lipid microparticles for the stability enhancement of a dopamine prodrug
000533 (2010)	Aleksandra Glavaski [États-Unis] ; Tamas Virag [États-Unis] ; Thomas Mangatu [États-Unis] ; Michael Mcgrogan [États-Unis] ; Xue Wang [États-Unis] ; Martha Bohn [États-Unis]	Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
000546 (1999)	Wei Le ; Orla Conneely ; Linglong Zou ; Yi He ; Odila Saucedo ; Joseph Jankovic ; Dennis Mosier ; Stanley Appel	Selective Agenesis of Mesencephalic Dopaminergic Neurons in Nurr1-Deficient Mice
000554 (2009)	A Schapira [Royaume-Uni] ; M Emre [Turquie] ; P Jenner [Royaume-Uni] ; W Poewe [Autriche]	Levodopa in the treatment of Parkinson’s disease
000569 (2011)	T Archer [Suède] ; A Fredriksson [Suède] ; B Johansson [Suède]	Exercise alleviates Parkinsonism: clinical and laboratory evidence
000660 (2004)	Dina Ruano [Portugal] ; Ant Macedo [Portugal] ; Ana Dourado [Portugal] ; Maria Soares [Portugal] ; José Valente [Portugal] ; Isabel Coelho [Portugal] ; Vítor Santos [Portugal] ; Maria Azevedo [Portugal] ; Ann Goodman [États-Unis] ; Mara Hutz [Brésil] ; Clarissa Gama [Brésil] ; Maria Lobato [Brésil] ; Paulo Belmonte [Brésil] ; Joana Palha [Portugal]	NR4A2 and schizophrenia: Lack of association in a Portuguese/Brazilian study
000662 (1996)	Lynelle Johnson [États-Unis] ; Pragna Patel [États-Unis]	Lesch‐Nyhan syndrome: An overview of pharmacologic and molecular genetic aspects
000736 (2006)	Christopher Bishop [États-Unis] ; Jennifer Taylor [États-Unis] ; Donald Kuhn [États-Unis] ; Karen Eskow [États-Unis] ; John Park [États-Unis] ; Paul Walker [États-Unis]	MDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation
000753 (2009)	Tultul Nayyar [États-Unis] ; Michael Bubser [États-Unis] ; Marcus Ferguson [États-Unis] ; M Diana [États-Unis] ; J Shawn [États-Unis] ; Thomas Montine [États-Unis] ; Ariel Deutch [États-Unis] ; Twum Ansah [États-Unis]	Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation
000758 (1996)	T Brannan [États-Unis] ; A Prikhojan [États-Unis] ; D Yahr [États-Unis]	An in vivo comparison of the capacity of striatal versus extrastriatal brain regions to form dopamine from exogenously administered L-dopa
000765 (2005)	B Jakobsen [Danemark] ; J Gramsbergen [Danemark] ; A M [Danemark] ; C Rosenblad [Danemark] ; J Zimmer [Danemark]	Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP+ toxicity by GDNF
000816 (2011)	Cécile Bétry [France] ; Adeline Etiévant [France] ; Laura Lambás [France] ; Andrew Mccreary [Pays-Bas] ; Nasser Haddjeri [France]	In vivo effects of pardoprunox (SLV308), a partial D2/D3 receptor and 5‐HT1A receptor agonist, on rat dopamine and serotonin neuronal activity

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i -k "dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/KwdEn.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    JankovicV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    dopamine
}}

---

This area was generated with Dilib version V0.6.19. Data generation: Wed Feb 10 22:03:07 2016. Site generation: Tue Feb 13 16:14:27 2024